Document is current
Any future updates will be listed below
-
Authors
Tan, Baoying https://orcid.org/0000-0001-7339-5101
Lin, Ailing https://orcid.org/0000-0002-7667-8294
Han, Rong https://orcid.org/0009-0004-1589-6636
Bai, Lu https://orcid.org/0009-0006-1911-4245
Sun, Jing https://orcid.org/0000-0002-5130-4835
Hu, Shanlian https://orcid.org/0000-0002-6240-695X
Xuan, Jianwei https://orcid.org/0000-0003-4800-4935
-
Funding
Funding for this research was provided by:
Bayer Healthcare Company Ltd.
- License Information
-
More Information
Article History
Received: 13 October 2024
Accepted: 28 January 2025
First Online: 28 February 2025
Declarations
:
: Rong Han and Lu Bai are employees of Bayer Healthcare Company Ltd. Shanlian Hu, Jianwei Xuan, Baoying Tan, Ailing Lin, and Jing Sun state that they had no interests that might be perceived as posing a conflict or bias.
: In accordance with the ethical review requirements of the Chinese government and Bayer’s Standard Operating Procedures (SOP), the stakeholder survey did not involve the collection or recording of biological samples or medical data from patients and therefore did not require ethics committee review. All stakeholders provided informed consent to participate and agreed to the publication of their responses in this manuscript.
